Sermorelin is a synthetic peptide composed of the first 29 amino acids of growth hormone-releasing hormone (GHRH), the naturally occurring hormone that stimulates the pituitary gland to release growth hormone (GH). Sermorelin was approved by the FDA in the late 1990s under the brand name Geref Diagnostic, primarily for diagnostic use in paediatric growth hormone deficiency (GHD). It functions by stimulating endogenous GH production rather than replacing GH directly, potentially offering a more physiologically regulated hormone profile.
In clinical studies, such as a trial published in The Journal of Clinical Endocrinology & Metabolism (1999), Sermorelin effectively increased serum GH and insulin-like growth factor 1 (IGF-1). has also been explored off- label in adults for age-related GH decline, with some reports indicating improved sleep, energy, body composition, and recovery. Unlike synthetic GH therapy, Sermorelin was voluntarily discontinued by the manufacturer in the U.S. for commercial reasons, not due to safety or efficacy concerns.
- Product Name: CJC-1295 no DAC
- Molecular Formula: C149H246N44O42S
- Molecular Weight: 3357.93 g/mol
- CAS Number: 114466-38-7
- Unit weight: 2mg
- Form: Lyophilised Solid
USAGE AND STORAGE
CJC-1295 no DAC is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments. For optimal results store out of direct sunlight between 2-8 C° both before and after reconstitution. When reconstituting we recommend XL Peptides approved Bacteriostatic mixing water. When reconstituting ensure the peptide and mixing solution are at room temperature to prevent temperature shock and aid proper dilution.
SYNTHESIS AND QUALITY ASSURANCE
This peptide is meticulously synthesised through a controlled process that ensures high purity, making it suitable for advanced scientific studies. Our commitment to excellence guarantees that each batch undergoes stringent quality control.
